1. Government of India. National Medical Commission Registered Medical Practitioner (Professional Conduct) Regulations, 2023; 2023.
2. The Times of India. NMC Puts on Hold its Regulations Mandating Doctors to Prescribe Generic Drugs, Bar them from Endorsing any Drug Brand – Times of India. Available from: https://www.timesofindia.indiatimes.com/business/india-business/nmc-puts-on-hold-its-regulations-mandating-doctors-to-prescribe-generic-drugs-bar-them-from-endorsing-any-drug-brand/articleshow/103033647.cms?from=mdr. [Last accessed on 2023 Sep 09].
3. Economic Times Health World. Commission Puts Registered Medical Practitioner Regulations, 2023 on Hold – ET HealthWorld. Available from: https://health.economictimes.indiatimes.com/news/policy/commission-puts-registered-medical-practitioner-regulations-2023-on-hold/103061566. [Last accessed on 2023 Sep 09].
4. Generic anticancer drugs of the Jan Aushadhi scheme in India and their branded counterparts: The first cost comparison study;George;Cureus,2021
5. A comparative evaluation of price and quality of some branded versus branded-generic medicines of the same manufacturer in India;Singal;Indian J Pharmacol,2011